liposomal glutathione review systematic or meta-analysis Liposomal drug delivery system for

Pinholt M, Larner-Svensson H, Littauer P, Moser CE, Pedersen M, Lemming LE, et al

It's all such a pickle

How might this neuroimmune approach transform treatment strategies for other autoimmune conditions

As pharmacological treatments to enhance rehabilitation and improve outcomes in the post-acute and chronic phase after stroke are lacking, clinical testing of C3aR agonists is warranted

J Pharmacol Exp Ther 326:633645 Moschetti V, Desch M, Goetz S, Liesenfeld K-H, Rosenbrock H, Kammerer K-P, Wunderlich G, Wind S (2018) Safety, tolerability and pharmacokinetics of oral BI 425809, a glycine transporter 1 inhibitor, in healthy male volunteers: a partially randomised, single-blind, placebo-controlled, first-in-human study